X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs NOVARTIS - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER NOVARTIS PFIZER/
NOVARTIS
 
P/E (TTM) x 34.5 393.4 8.8% View Chart
P/BV x 5.4 31.5 17.3% View Chart
Dividend Yield % 0.6 1.5 43.1%  

Financials

 PFIZER   NOVARTIS
EQUITY SHARE DATA
    PFIZER
Mar-18
NOVARTIS
Mar-18
PFIZER/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs2,365758 312.0%   
Low Rs1,625579 280.7%   
Sales per share (Unadj.) Rs430.3228.4 188.4%  
Earnings per share (Unadj.) Rs78.731.7 248.0%  
Cash flow per share (Unadj.) Rs93.232.8 284.4%  
Dividends per share (Unadj.) Rs20.0010.00 200.0%  
Dividend yield (eoy) %1.01.5 67.0%  
Book value per share (Unadj.) Rs586.5297.1 197.4%  
Shares outstanding (eoy) m45.7524.69 185.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.62.9 158.4%   
Avg P/E ratio x25.321.1 120.3%  
P/CF ratio (eoy) x21.420.4 104.9%  
Price / Book Value ratio x3.42.2 151.2%  
Dividend payout %25.431.5 80.7%   
Avg Mkt Cap Rs m91,27116,505 553.0%   
No. of employees `0002.60.7 393.7%   
Total wages/salary Rs m3,1431,445 217.5%   
Avg. sales/employee Rs Th7,484.88,441.3 88.7%   
Avg. wages/employee Rs Th1,195.02,163.6 55.2%   
Avg. net profit/employee Rs Th1,369.11,173.1 116.7%   
INCOME DATA
Net Sales Rs m19,6855,639 349.1%  
Other income Rs m1,1431,718 66.5%   
Total revenues Rs m20,8287,357 283.1%   
Gross profit Rs m5,003-63 -8,004.6%  
Depreciation Rs m66325 2,618.6%   
Interest Rs m455 7.6%   
Profit before tax Rs m5,4791,575 347.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,878792 237.3%   
Profit after tax Rs m3,601784 459.5%  
Gross profit margin %25.4-1.1 -2,292.9%  
Effective tax rate %34.350.3 68.2%   
Net profit margin %18.313.9 131.6%  
BALANCE SHEET DATA
Current assets Rs m24,1679,522 253.8%   
Current liabilities Rs m9,5443,296 289.6%   
Net working cap to sales %74.3110.4 67.3%  
Current ratio x2.52.9 87.7%  
Inventory Days Days5537 150.4%  
Debtors Days Days2928 101.0%  
Net fixed assets Rs m9,51446 20,681.7%   
Share capital Rs m458123 370.7%   
"Free" reserves Rs m26,3757,213 365.7%   
Net worth Rs m26,8327,336 365.7%   
Long term debt Rs m250-   
Total assets Rs m36,90011,105 332.3%  
Interest coverage x1,305.529.5 4,427.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.5 105.1%   
Return on assets %9.87.6 129.3%  
Return on equity %13.410.7 125.6%  
Return on capital %20.422.2 91.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2261 37.0%   
Fx outflow Rs m1,4893,630 41.0%   
Net fx Rs m-1,466-3,570 41.1%   
CASH FLOW
From Operations Rs m3,3181,610 206.1%  
From Investments Rs m-2,383687 -346.9%  
From Financial Activity Rs m-1,104-2,677 41.2%  
Net Cashflow Rs m-169-380 44.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 75.0 85.2%  
Indian inst/Mut Fund % 7.5 2.0 375.0%  
FIIs % 4.9 1.6 306.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 21.5 110.2%  
Shareholders   85,207 41,647 204.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   SUVEN LIFESCIENCES  SUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  SHASUN PHARMA  

Compare PFIZER With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Get Ready for Record Highs(Podcast)

Globally, Traders were left scrambling after the Federal Reserve forecast zero interest-rate hikes this year and just one in 2020.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

NOVARTIS Announces Quarterly Results (2QFY19); Net Profit Down 64.1% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, NOVARTIS has posted a net profit of Rs 94 m (down 64.1% YoY). Sales on the other hand came in at Rs 1 bn (down 36.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Mar 22, 2019 (Close)

TRACK PFIZER

PFIZER - TORRENT PHARMA COMPARISON

COMPARE PFIZER WITH

MARKET STATS